Fri, October 28, 2016
Thu, October 27, 2016

Matthew Kaplan Upgraded (UTHR) to Strong Buy on, Oct 28th, 2016

Matthew Kaplan of Ladenburg Thalmann, Upgraded "United Therapeutics Corporation" (UTHR) to Strong Buy on, Oct 28th, 2016.

Matthew has made no other calls on UTHR in the last 4 months.



There is 1 other peer that has a rating on UTHR. Out of the 1 peers that are also analyzing UTHR, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $129 on, Friday, July 29th, 2016